Search

everythinglearnresearchcommunity

for

Search:↓

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

Purpura fulminans can signal underlying autoimmune disorders, not just infections.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

Atypical symptoms in lupus can indicate different kidney issues.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Middle-aged women with dilated cardiomyopathy should be screened for antiphospholipid syndrome.

Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Quiescent cells have increased mitochondrial activity and ECM gene expression, but reduced glycolysis.

iPSC-derived artificial platelets show promise for consistent and effective regenerative therapies.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

An 18-year-old girl improved with treatment after being diagnosed with both Systemic Lupus Erythematosus and Celiac Disease.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Microneedles could revolutionize pediatric medicine by offering painless drug delivery, but more development is needed.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

HS patients rarely see dermatologists, often get opiates, and need better care.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Psoriatic alopecia is a challenging hair loss condition linked to psoriasis, needing better diagnosis and personalized treatments.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.